Exposure of the CeO 2 nanoparticles (NPs) causes a public concern on their potential health risk due to their wide applications in the fields of fuel additive, commodities, pharmaceutical, and other industries. In this study, the interactions between two commercial CeO 2 NPs (D-CeO 2 from Degussa and PC-CeO 2 from PlasmaChem) and mouse leukemic monocyte macrophage Raw264.7 cells were investigated to provide a fast and in-depth understanding of the biological influences of the NPs. Both types of the CeO 2 NPs had a negative surface charge around -12 mV and showed a tendency to form aggregates with sizes of 191 ± 5.9 and 60.9 ± 2.8 nm in cell culture environment, respectively. The cellular uptake of the CeO 2 NPs increased along with the increase of feeding dosage and prolongation of the culture time. The PC-CeO 2 NPs had a faster uptake rate and reached higher cellular loading amount at the highest feeding concentration (200 lg/mL). In general, both types of the CeO 2 NPs had rather small cytotoxicity even with a dosage as high as 200 lg/mL. The D-CeO 2 NPs showed a relative stronger cytotoxicity especially at higher concentrations and longer incubation time. The NPs were dispersed in vacuoles (most likely endosomes and lysosomes) and cytoplasm. Although both types of the CeO 2 NPs could suppress the production of reactive oxygen species, they impaired the mitochondria membrane potential to some extent. The cytoskeleton organization was altered and consequently the cell adhesion ability decreased after uptake of both types of the CeO 2 NPs.